Cancer vaccines will become more expensive after the government considers adding the human papillomavirus (HPV) vaccine to the national immunization program
Piramal Pharma Ltd detailed a 14% year-on-year ascend in its united income from tasks to ₹1,959 crore in the December finished quarter (Q3FY24), driven areas of strength for by across its verticals.
Glenmark said it has collaborated with Pfizer to send off abrocitinib in India utilized for treatment of moderate-to-extreme atopic dermatitis (Promotion). Glenmark and Pfizer will co-market abrocitinib in India under the brand names JABRYUS and...
QIAGEN has launched two disease test panels for its QIAstat-Dx device in India, including the gastrointestinal panel two and meningitis/encephalitis panel
Fresenius Kabi is posaconazole, an alternative to Noxafil, which treats or prevents severe fungal infections in adults and children at risk of developing fungal infections due to a weakened immune system.
Glenmark Pharmaceuticals Ltd. (Glenmark), a research-focused global pharmaceutical company, and Ichnos Sciences Inc. (Ichnos), an international clinical technology subsidiary, announced the launch of its partnership, Ichnos Glenmark Innovation.
Bajaj Finserv Health, a wholly owned subsidiary of Bajaj Finserv, acquired the entire stake in Vidal Healthcare Services for an enterprise value of Rs 325 crore.
The London Borough of Sutton has confirmed that it has chosen insurer Aviva and developer Socius as partners to progress the development of a world-leading site for cancer research and treatment at the London Cancer Hub (LCH) in Sutton, London
India needs investigator-led clinical trials, especially in oncology. Dr BS Ajaikumar, chairman of HealthCare Global Enterprises, said there should be more opportunities to conduct cross-sectional studies.
Dr Reddy's Research facilities Ltd. (DRL) beat expert assumptions to report a net profit of ₹1,378.9 crore in the second from last quarter finished December (Q3FY24), a 11% year-on-year rise, helped by piece of the pie gains. During that time, the...